247 related articles for article (PubMed ID: 33054540)
21. Expression of OPN3 in lung adenocarcinoma promotes epithelial-mesenchymal transition and tumor metastasis.
Xu C; Wang R; Yang Y; Xu T; Li Y; Xu J; Jiang Z
Thorac Cancer; 2020 Feb; 11(2):286-294. PubMed ID: 31802643
[TBL] [Abstract][Full Text] [Related]
22. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
[TBL] [Abstract][Full Text] [Related]
23. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
24. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
Chen Y; Tang J; Lu T; Liu F
Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
[TBL] [Abstract][Full Text] [Related]
25. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
[TBL] [Abstract][Full Text] [Related]
27. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Xuan YW; Liao M; Zhai WL; Peng LJ; Tang Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8411-8421. PubMed ID: 31646571
[TBL] [Abstract][Full Text] [Related]
30. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract][Full Text] [Related]
32. High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial-mesenchymal Transition.
Pang Z; Wang Y; Ding N; Chen X; Yang Y; Wang G; Liu Q; Du J
Sci Rep; 2019 Feb; 9(1):1324. PubMed ID: 30718593
[TBL] [Abstract][Full Text] [Related]
33. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
34. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
35. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
37. TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin.
Xu W; Chen B; Ke D; Chen X
Aging (Albany NY); 2020 Jul; 12(13):13488-13501. PubMed ID: 32640423
[TBL] [Abstract][Full Text] [Related]
38. PIEZO1 acts as a cancer suppressor by regulating the ROS/Wnt/β-catenin axis.
Bo H; Wu Q; Zhu C; Zheng Y; Cheng G; Cui L
Thorac Cancer; 2024 Apr; 15(12):1007-1016. PubMed ID: 38494915
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.
Zhang Y; Wang LF; Gao JH; Li L; Jiang P; Lv X; Yu LX; Yang J; Li RT; Liu BR
Curr Oncol; 2019 Apr; 26(2):e121-e127. PubMed ID: 31043817
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
